A B S T R A C T Crossed immunoelectrophoresis of Triton X-100 solubilized proteins from normal and abnormal platelets was performed with rabbit antibodies raised against normnal platelets. In Bernard-Soulier platelets protein 13 was not detected, and neither the amphiphilic (probably GP Ib) nor the hydrophilic (glycocalicin) glycocalicin-related proteins were seen when monospecific antiglycocalicin antiserum was used. The most prominent precipitate, 16, and platelet fibrinogen, 24 were not detected in platelets of two patients with type I thrombasthenia, whereas in one patient with type II thrombasthenia fibrinogen was clearly detected, but the amount of protein 16 remained severely reduced. Protein 16 was heavily labeled after lactoperoxidase-catalyzed 1251 iodination ofnormal platelets, and was precipitated by IgG-L, an alloantibody from a polytransfused thrombasthenic patient. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or protein 16 cut out from immunoplates showed two 125I-labeled glycoprotein bands, which migrate as GP Ilb and GP Illa. SDS-PAGE of 1251_ labeled type I thrombasthenic platelets showed no periodic acid-Schiff bands or peaks of radioactivity in the GP Ilb and GP Illa regions, whereas in the GP I region both the periodic acid-Schiff band intensity and the radiolabeling were within the normal range. Autoradiography after crossed immunoelectrophoresis of iodinated thrombasthenic platelets showed that the bulk of radioactivity was bound to protein 17. This glycoprotein, which was also present in normal and Bernard-Soulier platelets, migrates in the GP I region on SDS-PAGE. Thus, the bulk of radioactivity ob- (7), and glycocalicin (GPS or GP Is) couild not be dletected (8, 9) . \Ve have found a normal pattern of protein (7, 10) and a normal distribution of radioactivity after SDS-PAGE of Bernard-Soulier platelets that ha(l been labele(d by lactoperoxidase-catalvzed iodination (10), whereas others have reported a grossly abnormial protein pattern and distribution of 1251-labeled proteins (11).
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INTRODUCTION
Blood platelets play a crucial role in hemostasis by adhering to the exposed subendothelial tissue at the site of the vessel wall injury, followed by aggregate formation caused by the synthesis of prostaglandini metabolites and the secretion of intracellularly stored ADP. The Bernard-Soulier syndrome an(l Glanzmann's thrombasthenia are inherited bleeding disorders resulting from an impaired platelet funiction (1) (2) (3) .
Bernard-Soulier platelets tend to be of an increased size on blood smears, do not adhere normally to subendothelial tissue, and do not agglutinate in the factor VIII-dependent systems. However, they do undergo the release reaction upon thrombin stimulation and aggregate with ADP. In contrast, thrombasthenic platelets do not aggregate with ADP, but the adhesion to subendothelial tissue, the release reaction, and the factor VIII-dependent agglutination occur normally or relatively nonrally. In type I thrombastheinia no clot retraction occurs, and the platelets contain little or no fibrinogen. In type II thrombasthenia clot retraction is present but reduced (-50% of normal), the platelet fibrinogen content is normnal, but the platelet ATP content reduced (recent reviews on the platelet defects in the Bernard-Soulier syndrome and thrombasthenia; 4, 5).
Studies on Bernard-Soulier and thrombasthenic platelets may, therefore, be useful in detecting f:actors that are essential for normal platelet functions. A mnembrane defect in Bernard-Soulier platelets was first suggested by Gr0ttum and Solumil (6) who foundl a reduced electrophoretic mnobility combined with a re-duced content of sialic acidl per unit surface area of these cells. Comparison of the glvcoprotein comilpositionl of normiial and Bernard-Souilier platelets 1y sodium dcldecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)' have further showni a reduced periodic acid-Schiff (PAS) stain intensity of a 155,000 mol xvt glNcoprotein (GP I region) in Bernard-Soulier platelets (7) , and glycocalicin (GPS or GP Is) couild not be dletected (8, 9) . \Ve have found a normal pattern of protein (7, 10) and a normal distribution of radioactivity after SDS-PAGE of Bernard-Soulier platelets that ha(l been labele(d by lactoperoxidase-catalvzed iodination (10) , whereas others have reported a grossly abnormial protein pattern and distribution of 1251-labeled proteins (11) .
Thrombasthenic platelets show a strongl redtuced PAS stain intensity of GP Ilb and GP lIla (GP III) comparedl to normiial (8, 12, 13) anid very little ra(lioactivity was seen in these regions after SDS-PAGE of iodinatedl, thromnibastheniic platelets (10, 13) . However, SDS-PAGE is not well suiitedl for quantitative measturemenits of' proteins, anlI such an anialysis is further complicated by the facit that certaiin proteinis may comigrate in some SDS-PAGE systems (10, 14) . Crossed immllunoelectrophoresis in the presence of nlonlionlic detergent has proved to be a useful tool in the stuidy of imemiibrane proteins (15, 16) . This two-dimensionial system permits qualitative characterization as well as a semi-quantitative estimate of the individual protein antigens. Crossed immllunoelectrophoresis of Triton X-100 extracts of normal platelets using corresponding rabbit antibodies has revealed more than 20 precipitates, andl several of these have been characterized according to their subcellular localization, carbohydrate content, amphiphilic nature, andl topography (16) . In the present investigation this technidjue has been used to examine platelets isolated from patients with the Bernard-Soulier syndromne and Glanzmann's thromnbastheinia.
MIETHODS
Patietits. Platelets were obtained with informed consent from two Bernard-Soulier (N.V. andI G.B.) and three thrombasthenic patients (NI.A., A.C., andl J.H.). The case history of N.V. was given by Caeni et al. (7) and that of G.B. was first reportedl by Bernar(l et al. (17) (23, 24) . The purified immulnoglobulini fraction isolated from serumii was kindly providled by Dr. G. Tobelem, H6pital Saint-Louis, Paris, Franice.
Imimnnoelectrophoretic anialysis. Crossed immiiuntoelectrophoresis was perfO)rmed in 1% (wt/vol) agarose gels conitaininlg 1% (vol/vol) Triton X-100 (22) . The solubilized proteins were separated in the first dimenisioni electrophoresis (10 V/cm, 45 min) and immllunioprecipitationi took place in the antibody-containiing gel (500 gg/cm2) dturing the secondl dimension electrophoresis (2 V/cm, 18-20 h). Quantitation of the individual peak area vas performed by planimetrv (25) , and the area expressed in arbitarv units.
SDS-PAGE. SDS-PAGE, (T:6.2%, C:0.32%) of normiial and thrombastheniic platelets were performedl as described bh Laemmllli (26) . Platelet samiiples were prepared bh incubationi at 37°C for 1 h in 2% SDS that conitainied 10 mmol/ liter Tris, 150 mmllol/liter NaCl, 3 mmllol/liter EDTA, andl 5 mmllol/liter N-ethvlmaleimide. Samples were redluce(d by inc.ubationi with 5% (vol/vol) 2-mercaptoethaniol at 37°C for 1 h before the application. Molecular weight miiarkers were run in parallel (high molecular weight kit, Bio-Rad Laboratories, Richmond, Calif.). Solubilizationi of proteinis in an immnlunoprecipitate was performed by inicutbatinig the gel pieces as cut from 4-8 washled, unlstainiedi imnitinoplates as dlescribe(l above (27 (16) . This is a result of the uise of a different antibody pool. Proteinis are numbered according to their position relative to the anode as described earlier (16) . Auitoradiographic anialysis of the dried imnllltliloplates revealed heavy labeling of protein 16 (Fig. IB) . Some radioactivity was associatecl with protein 17, whereas only traces of radioactivity were seeni associated with proteini 6, 20, 23, anid 24.
To assess the reproducibility of the crossed immunnloelectrophoresis procedcure, the area of immlilunoprecipitate 6 anid 16 were determined from parallel experimnenits uisinig the samr-e Triton extract. The ratio between the area of' 16 anid 6 was 2.10±0.08 (mean±SD; it = 7), and the individutal peak areas were 45.4±12 anid 21 .4±5 arbitrary (mean-±SD, ni = 7) for proteini 16 and 6, respectively. The variation that occturre(l in the peak area was examinied by crossed immuiiitinoelectrophoresis of platelet extracts fromi differenit niormlal donors. In this case, the ratio betweeni the area of protein 16 and 6 was 1.88±0.43 (mean±+SD, it = 9).
Crosse(d immntiiioelectrophoresis of the platelet extract against antiplatelet antibodies using an intermediate gel conitaininig a specific antiglycocalicin anitisertumii resuilted in the formlation of a double-peak imnlllliloprecipitate correspondling to protein 13 (Fig.  IC) . The smiiall, fiast-miiigratinig peak has beeni shown to represenit the hydrophilic proteini gl\cocalicini (GPS or GP Is) becauise a specific increase in tihe area of this peak was observed when purified glycocalicini was applie(l together wvith the Triton-solubilize(d platelet proteins (addition experim neilt). (Fig. ID and E) . Both the protein staini (Fig. ID) aind the atutoradography (Fig. IE) revealed that the whole of banid 16 was retained in the intermediate gel. To further characterize protein 16, this precipitate was carefilly cut out from washed, uinstainied imimunioplates. After solubilizationi in SDS, the mnaterial was examined by SD)S-PAGE (Fig. 2) . The upper curve (Fig. 2A) (Fig. 21) ) dcue to their content of inter-andl intranmolecular disuilphide bonds (13) . The two high mlolecuilar weight polypeptidles in the proteini 16 imnmunioprecipitate exhibit similar chaniges in their migration. (Fig. 2C) LvAA. and the extent of the radiolabeling were similar to that observed in normal platelets.
Crossed immunoelectrophoresis performned on Triton X-100-solubilized platelet proteins from two patients with Glanzmann's thrombasthenia, type I (M.A. and A.C.) showed the absence of the major immunoprecipitate, protein 16 (Fig. 4) . Furthermore, no immunoprecipitate was detected when IgG-L was incorporated in the intermediate gel. In these patients protein 24, which has previously been identified as platelet 5 (C) 8 13 of protein 13 was a specific abnormality, the other major immunoprecipitates were clearly detected. The reduced area below protein 16 and the other membrane proteins is probably caused by the increased size of the Bernard-Soulier platelets, which results in and increase in the amount of cytoplasmnic proteins relative to the membrane components.
Glatnzmutan's thrombasthentia, type L. Platelets from one patient with Glanzmann's thrombasthenia, type I (M.A.) were labeled by lactoperoxidase-catalyzed 1251 iodination. The glycoprotein pattern and the distribution of radioactivity after SDS-PAGE were compared to normal platelets. In normal platelets the bulk of radioactive material coincided with the GP IlIa band, and two smaller peaks were congruent with GP Ilb and GP I (GP lb and glycocalicin). In the thrombasthenic platelets no PAS bands could be detected in the GP Ilb and GP lIla regions, and no congruent peaks of radioactivity were seen. However, in the GP I region, both the intensity of the PAS bands fibrinogen (16) was absent or strongly reduced (Fig.  4, arrow) . When autoradiography of the iinmmunoplate obtained by crossed immnunoelectrophoresis of Triton X-100-solubilized proteins fromn 125I-iodinated thrombastheniic platelets was performed, onie prominent radioactive precipitate, (protein 17) was observed (Fig.  5B ). This protein was also present in normal platelets as demonstrated by an addition experiment using a mixture of labeled thrombastheniic and tunlabeled normal platelets as antigens (Fig. 5B) . In this case, the area below protein 17 increased conmpared to that obtained with the solubilized thrombasthenic platelets alone. Protein 16 could not be detected as a precipitate by crossed immunoelectrophoresis of tvpe I thromnbasthenic platelets. However, the auitoradiogramn obtained from the addition experimient revealed radioactive label associated with normal protein 16 ( Fig.   5B ), probably due to coprecipitation with smnall amounts of other radioactive proteins (27) . Glanzmanta's thromtibastheniia, tijpe Il. The Triton X-100 extract of the platelets from one patient with Glanzmanin's thrombasthenia, type II (J.H.), was examined by crosse(l immiuinoelectrophoresis (Fig. 6) . In this case, fibrinogen (No. 24) was clearly detected. Furthermore, an immunoprecipitate corresponding in electrophoretic mobility to protein 16 was detected, although it showed a strongly reduced area compared to that of normal platelets. The amount of protein 16 present in type II thrombastheniic platelets was calculated by planimetry to be 13% of normiial. Immlluniochemiiical identity between protein 16 from normal and type II thrombasthenic platelets has been demonstrated by precipitationv with IgG-L crossed affinoimmunoelectrophoresis and crossed hydrophobic-interaction immunoelectrophoresis (31) .
DISCUSSION
In this study, Triton X-100-solubilized proteinis from normiial and abnorm-al huimani platelets have been examinie(l l)v crossed immuniitiiioelectrophoresis uisinig anitibodies raised againist whole, normiial platelets. A further characterizationi of somiie of the individual immuntiiioprecipitates in the normiial reference patterni has beeni achieved, anid distinct protein abnormialities in BernardSoulier and thrombastheniic platelets have beeni demonistrate(l. The albsence of protein 13 and(I 16 in platelets from patients with Bernard-Soulier syndrome anic Glanzmiann's thrombasthenia type I, respectively, were specific abnormalities that were confirmiied both by use of moniospecific as well as wvith the polyNspecific antibodies.
The reproducibility of the metho(d w.as examiiniedl by performinig several electroplhoretic runls of the samiie platelet extract. A stand(lard deviation of the peak area of ± 10% was obtained, which is in accordanice with other studies on solubilized proteins (32) . A greater variation betweeni the ratio of peak 16 and 6 was observed vhen extracts from platelets isolated fromn different control dlonors xvere uised. Several (8, 13) . The presence of both GP Ilb and GP Illa in precipitate 16 suggests that these glycoproteins may exist together as a complex in the membrane, and that this complex is not broken by the nonionic detergent used to solubilize the platelet proteins. Alternatively, the glycoproteins may have a close affinity for each other and associate after the disruption of the membrane bilayer by the Triton X-100.
IgG-L, the human antibody obtained from a polytransfused thrombasthenic patient, formed an immunoprecipitate with protein 16. By using a double-immunoprecipitation technique, Degos and co-workers (24) have shown that the IgG-L interacted with a surface component of human platelets with a mol wt of 120,000 but did not identify the nature of this component. The relationship between our results and those of Degos and co-workers (24) is not yet clear, and is the subject of further investigation.
In type I thrombasthenia, no immunoprecipitate was formed with IgG-L, whereas small amounts of protein 16 were precipitated when solubili2ed proteins from type II thrombasthenic platelets were examined. On the basis ofdifferences in clot retraction and fibrinogen content, Caen (5) (38) , who showed deletion (<1%) of the platelet-specific alloantigen PlAl, in three thrombasthenic patients, whereas two other patients contained 12 and 22% of the normal values.
The profound functional abnormalities of BernardSoulier and thrombasthenic platelets may be related to the absence of protein 13 and 16, respectively. Further investigation on the properties of these proteins are in progress. 
